Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Susanne Kohlfuerst"'
Autor:
Peter Lind, I. Igerc, Hans-Juergen Gallowitsch, I. Gomez, Susanne Kohlfuerst, S. Matschnig, Ewald Kresnik
Publikováno v:
Thyroid. 16:1113-1119
The aim of our study was to determine whether treatment with a long-acting somatostatin-receptor analogue is effective in patients with (131)I-negative but somatostatin-receptor-positive metastases from dedifferentiated and anaplastic thyroid cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f223de1e6cdbe1fae987551c3b608e51
https://doi.org/10.1089/thy.2006.16.1113
https://doi.org/10.1089/thy.2006.16.1113
Autor:
I. Gomez-Segovia, Mohsen Beheshti, I. Igerc, Susanne Kohlfuerst, H.J. Gallowitsch, J. Mayr, S. Matschnig, Peter Lind, M. Lobnig, Peter Mikosch
Publikováno v:
European journal of nuclear medicine and molecular imaging. 36(6)
The purpose of this prospective study was to determine the diagnostic impact and influence on patient treatment of posttherapeutic (131)I SPECT-CT when the findings on planar posttherapeutic whole-body scintigraphy (ptWBS) were inconclusive.A total o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27b8b4266a1568bffe498083d9f6b694
https://pubmed.ncbi.nlm.nih.gov/19169681
https://pubmed.ncbi.nlm.nih.gov/19169681
Autor:
Ewald Kresnik, H.J. Gallowitsch, Susanne Kohlfuerst, I. Igerc, Michael Zoller, Peter Lind, I. Gomez
Publikováno v:
European journal of nuclear medicine and molecular imaging. 34(4)
18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is a well-established method in the follow-up of patients with differentiated thyroid carcinoma (DTC), elevated thyroglobulin (Tg) and negative 131I scans. This retrospective clinical st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::338e99029d1c79efa78db1fb11570558
https://pubmed.ncbi.nlm.nih.gov/17103166
https://pubmed.ncbi.nlm.nih.gov/17103166
Publikováno v:
Thyroid : official journal of the American Thyroid Association. 15(4)
There is no doubt that the availability of recombinant human thyrotropin (rhTSH) is one of the milestones in the management of patients with differentiated thyroid cancer (DTC). It offers the opportunity to obtain representative serum thyroglobulin (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afe68a07e592925791cb2a3708fb718d
https://pubmed.ncbi.nlm.nih.gov/15876162
https://pubmed.ncbi.nlm.nih.gov/15876162
Publikováno v:
Clinical Nuclear Medicine. 28:838-839
A 45-year-old man had chronic osteomyelitis in the right tibia since 1996 and developed severe shoulder pain recently. Bone scintigraphy was performed to exclude additional osteomyelitis originating from the primary site. Because of the bone scan res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d05375746466d41cbf8b6da3a629a88
https://doi.org/10.1097/01.rlu.0000090943.11941.26
https://doi.org/10.1097/01.rlu.0000090943.11941.26
Publikováno v:
Thyroid; Apr2005, Vol. 15 Issue 4, p371-376, 6p